New research suggests that people who come off popular GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop conventional diet and exercise plans.
Published data in a major medical journal shows that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying these medications should be informed of the danger of fast rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.
Such speed of regain suggests a return to starting mass within about one and a half years.
Comparing Approaches
The research, which looked at 37 of trials involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone typically see a slower weight regain—approximately 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Doctors suggest the way of the drugs is key to understanding the heightened weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and could lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
Medical guidelines recommend the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts say that, given the high risk of weight regain, the treatment is often long-term.
This view is supported by pharmaceutical companies, who note that the results "underscore the chronic nature of obesity," akin to managing conditions like diabetes.
User Testimonies
Users who have come off the medication explain a intense return of appetite.
"It was like something flipping and I was suddenly ravenous," described a patient.
The struggle is exacerbated if individuals have not adopted permanent lifestyle or habit modifications during treatment.
Growing Adoption
Survey data suggest that millions of people in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is higher among females than men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Finally, experts caution that while the jabs are effective tools for shedding pounds, they are not a standalone solution and lasting health benefits relies on integrated lifestyle changes.
